Hip and other fragility fracture incidence in real-world teriparatide-treated patients in the United States.

Saved in:
Bibliographic Details
Title: Hip and other fragility fracture incidence in real-world teriparatide-treated patients in the United States.
Authors: Burge RT; Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN, 46285, USA. burge_russel_thomas@lilly.com.; University of Cincinnati, Cincinnati, OH, USA. burge_russel_thomas@lilly.com., Disch DP; Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN, 46285, USA., Gelwicks S; Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN, 46285, USA., Zhang X; Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN, 46285, USA., Krege JH; Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN, 46285, USA.
Source: Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA [Osteoporos Int] 2017 Mar; Vol. 28 (3), pp. 799-809. Date of Electronic Publication: 2016 Dec 27.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Springer International Country of Publication: England NLM ID: 9100105 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1433-2965 (Electronic) Linking ISSN: 0937941X NLM ISO Abbreviation: Osteoporos Int Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1433-2965
DOI:10.1007/s00198-016-3888-9